To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Referred to the Subcommittee on Health.
Legislative search
Search official legislative data by topic, bill status, sponsor geography, representative, committee, subject, and recent law activity.
Use result counts to narrow this search.
Copy or share the current query and filters.
Saved searches, collections, and site alerts require an account.
Referred to the Subcommittee on Health.
Became Public Law No: 116-94. [Congressional Record Volume 165, Number 51 (Monday, March 25, 2019)] [House] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] By Mr. PASCRELL: H.R. 1865. Congress has the power to enac...